位置:首页 > 蛋白库 > BNP_CRODU
BNP_CRODU
ID   BNP_CRODU               Reviewed;         181 AA.
AC   Q90Y12; Q90Y11;
DT   20-MAY-2008, integrated into UniProtKB/Swiss-Prot.
DT   01-DEC-2001, sequence version 1.
DT   25-MAY-2022, entry version 55.
DE   RecName: Full=Bradykinin potentiating and C-type natriuretic peptides;
DE   AltName: Full=BPP-CNP;
DE   Contains:
DE     RecName: Full=Bradykinin-potentiating peptide Cdt1a;
DE   Contains:
DE     RecName: Full=Bradykinin-potentiating peptide Cdt1b;
DE   Contains:
DE     RecName: Full=Bradykinin-potentiating peptide Cdt2;
DE   Contains:
DE     RecName: Full=Bradykinin inhibitor peptide Cdt3;
DE   Contains:
DE     RecName: Full=C-type natriuretic peptide;
DE              Short=CNP;
DE   Flags: Precursor;
OS   Crotalus durissus terrificus (South American rattlesnake).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Lepidosauria; Squamata; Bifurcata; Unidentata; Episquamata; Toxicofera;
OC   Serpentes; Colubroidea; Viperidae; Crotalinae; Crotalus.
OX   NCBI_TaxID=8732;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, AND SYNTHESIS OF 28-40; 31-40; 44-49
RP   AND 53-58.
RC   TISSUE=Venom gland;
RX   PubMed=17714693; DOI=10.1016/j.bcp.2007.07.014;
RA   Gomes C.L., Konno K., Conceicao I.M., Ianzer D., Yamanouye N.,
RA   Prezoto B.C., Assakura M.T., Radis-Baptista G., Yamane T., Santos R.A.,
RA   de Camargo A.C.M., Hayashi M.A.F.;
RT   "Identification of novel bradykinin-potentiating peptides (BPPs) in the
RT   venom gland of a rattlesnake allowed the evaluation of the structure-
RT   function relationship of BPPs.";
RL   Biochem. Pharmacol. 74:1350-1360(2007).
RN   [2]
RP   PROTEIN SEQUENCE OF 31-40, SUBCELLULAR LOCATION, TISSUE SPECIFICITY, MASS
RP   SPECTROMETRY, AND PYROGLUTAMATE FORMATION AT GLN-31.
RC   TISSUE=Venom;
RX   PubMed=15912471; DOI=10.1002/rcm.1973;
RA   Wermelinger L.S., Dutra D.L., Oliveira-Carvalho A.L., Soares M.R.,
RA   Bloch C. Jr., Zingali R.B.;
RT   "Fast analysis of low molecular mass compounds present in snake venom:
RT   identification of ten new pyroglutamate-containing peptides.";
RL   Rapid Commun. Mass Spectrom. 19:1703-1708(2005).
CC   -!- FUNCTION: Bradykinin-potentiating peptide both inhibits the activity of
CC       the angiotensin-converting enzyme (ACE) and enhances the action of
CC       bradykinin by inhibiting the peptidases that inactivate it. It acts as
CC       an indirect hypotensive agent. Synthetic Cdt1a, Cdt1b and the short
CC       hexapeptide Cdt3 are able to potentiate the hypotensive effect mediated
CC       by Bk on the blood pressure of anesthetized rats.
CC       {ECO:0000269|PubMed:17714693}.
CC   -!- FUNCTION: Snake venom natriuretic peptide that exhibits hypotensive and
CC       vasodepressor activity. Acts by activating natriuretic receptors (NPR1
CC       and/or NPR2 and/or NPR3) (By similarity). {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Secreted {ECO:0000269|PubMed:15912471}.
CC   -!- TISSUE SPECIFICITY: Venom gland. {ECO:0000269|PubMed:15912471}.
CC   -!- MASS SPECTROMETRY: [Bradykinin-potentiating peptide Cdt1b]:
CC       Mass=1255.36; Method=MALDI; Evidence={ECO:0000269|PubMed:15912471};
CC   -!- SIMILARITY: In the N-terminal section; belongs to the bradykinin-
CC       potentiating peptide family. {ECO:0000305}.
CC   -!- SIMILARITY: In the C-terminal section; belongs to the natriuretic
CC       peptide family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF308593; AAL09426.1; -; mRNA.
DR   EMBL; AF308594; AAL09427.1; -; mRNA.
DR   AlphaFoldDB; Q90Y12; -.
DR   GO; GO:0005576; C:extracellular region; IEA:UniProtKB-SubCell.
DR   GO; GO:0005179; F:hormone activity; IEA:InterPro.
DR   GO; GO:0008191; F:metalloendopeptidase inhibitor activity; IEA:UniProtKB-KW.
DR   GO; GO:0090729; F:toxin activity; IEA:UniProtKB-KW.
DR   GO; GO:0008217; P:regulation of blood pressure; IEA:UniProtKB-KW.
DR   GO; GO:0042311; P:vasodilation; IEA:UniProtKB-KW.
DR   InterPro; IPR000663; Natr_peptide.
DR   InterPro; IPR030480; Natr_peptide_CS.
DR   Pfam; PF00212; ANP; 1.
DR   PRINTS; PR00710; NATPEPTIDES.
DR   SMART; SM00183; NAT_PEP; 1.
DR   PROSITE; PS00263; NATRIURETIC_PEPTIDE; 1.
PE   1: Evidence at protein level;
KW   Cleavage on pair of basic residues; Direct protein sequencing;
KW   Disulfide bond; Hypotensive agent; Metalloenzyme inhibitor;
KW   Metalloprotease inhibitor; Protease inhibitor; Pyrrolidone carboxylic acid;
KW   Secreted; Signal; Toxin; Vasoactive; Vasodilator.
FT   SIGNAL          1..23
FT                   /evidence="ECO:0000255"
FT   PROPEP          24..27
FT                   /evidence="ECO:0000255"
FT                   /id="PRO_0000335906"
FT   PEPTIDE         28..40
FT                   /note="Bradykinin-potentiating peptide Cdt1a"
FT                   /evidence="ECO:0000250"
FT                   /id="PRO_0000335907"
FT   PEPTIDE         31..40
FT                   /note="Bradykinin-potentiating peptide Cdt1b"
FT                   /id="PRO_0000335908"
FT   PROPEP          41..43
FT                   /id="PRO_0000335909"
FT   PEPTIDE         44..49
FT                   /note="Bradykinin-potentiating peptide Cdt2"
FT                   /evidence="ECO:0000250"
FT                   /id="PRO_0000335910"
FT   PROPEP          50..52
FT                   /evidence="ECO:0000255"
FT                   /id="PRO_0000335911"
FT   PEPTIDE         53..58
FT                   /note="Bradykinin inhibitor peptide Cdt3"
FT                   /evidence="ECO:0000250"
FT                   /id="PRO_0000335912"
FT   PROPEP          59..157
FT                   /evidence="ECO:0000255"
FT                   /id="PRO_0000335913"
FT   PEPTIDE         160..181
FT                   /note="C-type natriuretic peptide"
FT                   /evidence="ECO:0000250"
FT                   /id="PRO_0000335914"
FT   REGION          74..150
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        103..117
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         28
FT                   /note="Pyrrolidone carboxylic acid"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         31
FT                   /note="Pyrrolidone carboxylic acid"
FT                   /evidence="ECO:0000269|PubMed:15912471"
FT   MOD_RES         44
FT                   /note="Pyrrolidone carboxylic acid"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         53
FT                   /note="Pyrrolidone carboxylic acid"
FT                   /evidence="ECO:0000250"
FT   DISULFID        165..181
FT                   /evidence="ECO:0000250"
FT   VARIANT         31
FT                   /note="Q -> H (in isoform 1)"
FT   VARIANT         36
FT                   /note="L -> P (in isoform 1)"
FT   VARIANT         144
FT                   /note="C -> G (in isoform 1)"
SQ   SEQUENCE   181 AA;  18560 MW;  7B5ADC5B9372D07F CRC64;
     MFVSRLAASG LLLLALLAVS LDGKPLQQWS QRWPHLEIPP LVVQNWKSPT QLQARESPAG
     GTTALREELS LGPEAALDTP PAGPDGGPRG SKAAAAAPQR LSKSKGASAT SAASRDLRTD
     GKQARQNWGR LVSPDHHSAA GGGCGGGGGA RRLKGLAKKR AGNGCFGLKL DRIGSMSGLG
     C
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2025